We are live on ! Find out more
BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

96 hedge funds and large institutions have $263M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 10

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

20% more funds holding

Funds holding: 80 → 96 (+16)

1% less capital invested

Capital invested by funds: $266M → $263M (-$2.99M)

79% less call options, than puts

Call options by funds: $350K | Put options by funds: $1.69M

Holders
96
Holders Change
+16
Holders Change %
+20%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
31
Increased
35
Reduced
22
Closed
10
Calls
$350K
Puts
$1.69M
Net Calls
-$1.34M
Net Calls Change
-$1.31M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$21.9M
2
FCMI
Foresite Capital Management III
California
+$12M
3
LP
LMR Partners
United Kingdom
+$3.54M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3M
5
UONDDL
University of Notre Dame du Lac
Indiana
+$2.75M

Top Sellers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
-$10.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.55M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.62M
4
EAM
Eventide Asset Management
Massachusetts
-$1.57M
5
Invesco
Invesco
Georgia
-$998K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMI
26
Foresite Capital Management II
California
$1.3M +$1.38M +10,500 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.18M +$12.2K +93 +1%
PA
28
Perceptive Advisors
New York
$1.06M +$1.13M +8,620 New
CA
29
Corrado Advisors
New Jersey
$1.03M +$1.1M +8,362 New
Principal Financial Group
30
Principal Financial Group
Iowa
$1.03M +$7.99K +61 +0.7%
MTC
31
McDaniel Terry & Co
Texas
$939K – – –
Wells Fargo
32
Wells Fargo
California
$939K +$475K +3,624 +91%
Charles Schwab
33
Charles Schwab
California
$910K +$53.8K +411 +6%
SM
34
Sabby Management
Florida
$895K +$950K +7,250 New
Creative Planning
35
Creative Planning
Kansas
$853K – – –
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$840K +$892K +6,806 New
Deutsche Bank
37
Deutsche Bank
Germany
$832K +$30.8K +235 +4%
SCM
38
Suffolk Capital Management
New York
$784K -$249K -1,901 -23%
TCM
39
Tekla Capital Management
Massachusetts
$740K – – –
TCIM
40
TIAA CREF Investment Management
New York
$711K -$25.4K -194 -3%
VIA
41
Vident Investment Advisory
Georgia
$698K +$124K +943 +20%
CC
42
Clearline Capital
New York
$681K +$723K +5,520 New
FAM
43
Fred Alger Management
New York
$617K +$39.3K +300 +6%
PRCM
44
Pine River Capital Management
Minnesota
$617K +$655K +5,000 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$547K +$196K +1,500 +51%
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$539K +$572K +4,370 New
Goldman Sachs
47
Goldman Sachs
New York
$526K +$182K +1,386 +48%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$509K -$26.2K -200 -5%
DADC
49
D.A. Davidson & Co
Montana
$442K -$2.62K -20 -0.6%
TA
50
Teachers Advisors
New York
$441K +$1.83K +14 +0.4%
1
2
3 4 5

BLCM Hedge Fund Activity: Q1 2017 in Review

96 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q1 2017, worth a combined $263M — down 1.1% from $266M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new BLCM positions and 10 closed out — a net gain of 21 holders — while 35 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $21.9M. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $10.6M sold.

  • 96 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q1 2017, up from 80 in Q4 2016.
  • Funds reported $263M of Bellicum Pharmaceuticals, Inc. stock for Q1 2017, down 1.1% quarter-over-quarter.
  • 31 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q1 2017 and 10 closed out, a net change of +21 holders.
  • The largest Bellicum Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $21.9M added.
  • The largest Bellicum Pharmaceuticals, Inc. seller in Q1 2017 was First Eagle Investment Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2017.